Mislabeling Leads to 17 Cases of Infant “Werewolf Syndrome”

Children in Spain have developed hypertrichosis after a reflux drug was contaminated with alopecia treatment.

Infant Werewolf Syndrome / Image: Shutterstock
Infant Werewolf Syndrome / Image: Shutterstock

The headline may sound like a festive Halloween ruse, but according to a recent European Pharmaceutical Review article, kids in Spain are developing ‘werewolf syndrome’ after a packaging error. There have been at least 17 cases reported in which infants have grown abnormal body hair after taking omeprazole for gastroesophageal reflux disease. The drug administered was contained minoxidil, a medication used to treat alopecia.

Farma-Química Sur, the company that produces the drug, purchased a batch of minoxidil from a generic drug supplier in India. A labeling error at the plant caused the two to be mixed, resulting in the hairy babies. The company told parents that the excess hair should fall out and the babies should be back to normal in a few weeks.

Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Researched List: Blister Machines for Life Sciences
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report